About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 4NCT01108978

Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

The purpose of this study is to evaluate the Efficacy and Safety of Dehypotin® in the Patients with Type 2 Diabetes Mellitus or Cardiovascular Disease. Eligible patients will be randomly assigned to 1...

Lead sponsor: Nang Kuang Pharmaceutical Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Nang Kuang Pharmaceutical Co., Ltd.

Collaborators

National Taiwan University Hospital

Age

20 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female
•Age 20-75 years
•Diagnosis of type II Diabetes Mellitus for at least 3 months and/or clinical evident cardiovascular disease (CVD)
•A hemoglobin A1c concentration has to be \< 8% before screening

Exclusion Criteria

•Women of child bearing potential who are pregnant, breastfeeding or not using effective contraceptives
•Known hypersensitivity to Pravastatin or any of its components
•Have a history of homozygous familial hypercholesterolemia or known type III hyperlipoproteinemia
•Significant medical illness
•Known serious conditions, e.g. serum creatine kinase(CK)levels 2.5 times upper limit of normal
•Subjects being treated with drugs influence serum lipid concentrations
•Subjects who have cancer or been receiving the cancer chemotherapy

Related studies

RECRUITINGPhase 3

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

NCT07136012 · Cardiovascular Disease

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

NCT06675552 · Heart Disease, Heart Failure, and more

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 9, 2011Terms

Trial snapshot

StatusTERMINATED

PhasePHASE4

Enrollment60

Start dateMay 2010

Last updatedJun 9, 2011

Condition

Type 2 Diabetes Mellitus Cardiovascular Disease Hypercholesterolemia

Locations shown

Nang Kuang Pharmaceutical Co., LTD

Tainan, Xinhua Township

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2011Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions